{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T06:50:15Z","timestamp":1791442215073,"version":"4.3.3"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54 AI-065357"],"award-info":[{"award-number":["U54 AI-065357"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.antiviral.2015.07.003","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T07:09:09Z","timestamp":1436857749000},"page":"132-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever"],"prefix":"10.1016","volume":"121","author":[{"given":"Brian B.","family":"Gowen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Sefing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonna B.","family":"Westover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald F.","family":"Smee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Hagloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousuke","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery O.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2015.07.003_b0005","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1128\/JVI.02346-12","article-title":"T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro","volume":"87","author":"Baranovich","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.07.003_b0010","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","article-title":"Hemorrhagic fever viruses as biological weapons: medical and public health management","volume":"287","author":"Borio","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2015.07.003_b0015","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.coi.2005.05.001","article-title":"Pathogenesis of viral hemorrhagic fever","volume":"17","author":"Bray","year":"2005","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.antiviral.2015.07.003_b0020","series-title":"Fields Virology","first-page":"1635","article-title":"Arenaviridae: the viruses and their replication","author":"Buchmeier","year":"2001"},{"key":"10.1016\/j.antiviral.2015.07.003_b0025","doi-asserted-by":"crossref","first-page":"e2790","DOI":"10.1371\/journal.pntd.0002790","article-title":"Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley Fever","volume":"8","author":"Caroline","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2015.07.003_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-199936001-00001","article-title":"Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers","volume":"36","author":"Cass","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.antiviral.2015.07.003_b0035","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/jac\/dku209","article-title":"Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral","volume":"69","author":"Delang","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2015.07.003_b0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00003088-197601020-00002","article-title":"Renal failure, drug pharmacokinetics and drug action","volume":"1","author":"Fabre","year":"1976","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.antiviral.2015.07.003_b0045","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.46.4.977-981.2002","article-title":"In vitro and in vivo activities of anti-influenza virus compound T-705","volume":"46","author":"Furuta","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.07.003_b0050","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.07.003_b9000","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1042\/bj0340764","article-title":"Liver aldehyde oxidase","volume":"34","author":"Gordon","year":"1940","journal-title":"Biochem. J."},{"key":"10.1016\/j.antiviral.2015.07.003_b0055","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1128\/AAC.00356-07","article-title":"In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections","volume":"51","author":"Gowen","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.07.003_b0060","doi-asserted-by":"crossref","first-page":"e3725","DOI":"10.1371\/journal.pone.0003725","article-title":"Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin","volume":"3","author":"Gowen","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2015.07.003_b0065","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/1743-422X-7-240","article-title":"Assessing changes in vascular permeability in a hamster model of viral hemorrhagic fever","volume":"7","author":"Gowen","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2015.07.003_b0070","doi-asserted-by":"crossref","first-page":"e2614","DOI":"10.1371\/journal.pntd.0002614","article-title":"Favipiravir (T-705) inhibits Junin virus infection and reduces mortality in a guinea pig model of Argentine hemorrhagic fever","volume":"7","author":"Gowen","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2015.07.003_b0075","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/v4102317","article-title":"Junin virus pathogenesis and virus replication","volume":"4","author":"Grant","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2015.07.003_b0080","doi-asserted-by":"crossref","first-page":"e68347","DOI":"10.1371\/journal.pone.0068347","article-title":"The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) ribofuranosyl 5\u2032-triphosphate towards influenza A virus polymerase","volume":"8","author":"Jin","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2015.07.003_b0085","unstructured":"Kobayashi, O., Noto, M., Sakurai, T., 2011. Favipiravir, A Novel Anti-Influenza Virus Compound Inhibits Viral RNA Polymerase: the Safety, Tolerability and Pharmacokinetics of Higher Dose in Human, Interscience Conference of Antimicrobial Agents and Chemotherapy, Chicago, IL."},{"key":"10.1016\/j.antiviral.2015.07.003_b0090","article-title":"Safety and pharmacokinetics of intravenous zanamivir treatment in hospitalized adults with influenza: an open-label, multicenter, single-arm, phase II study","author":"Marty","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.07.003_b0095","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1128\/AAC.01219-10","article-title":"T-705 (favipiravir) inhibition of arenavirus replication in cell culture","volume":"55","author":"Mendenhall","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.07.003_b0100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1586\/eri.10.142","article-title":"Pathogenesis of arenavirus hemorrhagic fevers","volume":"9","author":"Moraz","year":"2011","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.antiviral.2015.07.003_b0105","unstructured":"NIAID, 2015. Biodefense and Emerging Infectious Diseases, http:\/\/www.niaid.nih.gov\/topics\/biodefenserelated\/biodefense\/pages\/cata.aspx."},{"key":"10.1016\/j.antiviral.2015.07.003_b0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.antiviral.2014.02.014","article-title":"Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model","volume":"105","author":"Oestereich","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.07.003_b0115","doi-asserted-by":"crossref","first-page":"e2804","DOI":"10.1371\/journal.pntd.0002804","article-title":"Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever","volume":"8","author":"Oestereich","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2015.07.003_b0120","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3201\/eid1510.090211","article-title":"Nosocomial outbreak of novel arenavirus infection, southern Africa","volume":"15","author":"Paweska","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.07.003_b0125","doi-asserted-by":"crossref","first-page":"8441","DOI":"10.1021\/jm100888d","article-title":"Aldehyde oxidase: an enzyme of emerging importance in drug discovery","volume":"53","author":"Pryde","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2015.07.003_b0130","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.antiviral.2015.07.003_b0135","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.bbrc.2012.07.034","article-title":"Favipiravir (T-705) inhibits in vitro norovirus replication","volume":"424","author":"Rocha-Pereira","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2015.07.003_b0140","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1128\/AAC.00649-13","article-title":"Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase","volume":"57","author":"Sangawa","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.07.003_b0145","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.antiviral.2014.01.016","article-title":"Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment","volume":"104","author":"Scharton","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.07.003_b0150","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.antiviral.2014.01.012","article-title":"Post-exposure efficacy of oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model","volume":"104","author":"Smither","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.07.003_b0155","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/BF03261935","article-title":"Single-dose pharmacokinetics of boceprevir in subjects with impaired hepatic or renal function","volume":"51","author":"Treitel","year":"2012","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.antiviral.2015.07.003_b0160","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1124\/dmd.105.005306","article-title":"Involvement of molybdenum hydroxylases in reductive metabolism of nitro polycyclic aromatic hydrocarbons in mammalian skin","volume":"33","author":"Ueda","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.antiviral.2015.07.003_b0165","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.3390\/v4102031","article-title":"Pathogenesis of Lassa fever","volume":"4","author":"Yun","year":"2012","journal-title":"Viruses"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215001667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215001667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T19:53:37Z","timestamp":1537473217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354215001667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":34,"alternative-id":["S0166354215001667"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.07.003","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}